Medical Treatments: Innovation
Commons · Question 54194 · Tabled 21 May 2025 · Department of Health and Social Care · Official record
Answered 2 Jun 2025
Question
Asked by Clive Jones
To ask the Secretary of State for Health and Social Care, what steps the Medicines and Healthcare products Regulatory Agency is taking to increase access to innovative treatments.
Answer
Answered by Karin Smyth, 2 Jun 2025
The Medicines and Healthcare products Regulatory Agency (MHRA) plays a vital role in delivering the Government’s Life Sciences Vision and wider Plan for Change by enabling earlier and broader patient access to innovative treatments. The agency’s ambition ...